Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Hepatitis 1 Esophageal Stenosis 1 Esophageal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Brain Injuries 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Steroids × Clear all

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡